Interaction between PGI2 and ET-1 pathways in vascular smooth muscle from Group-III pulmonary hypertension patients
Gülsev Özen(Istanbul University), Xavier Norel(Inserm), Aurélie Cazes(Université Paris Cité), Adam M. Silverstein(United Therapeutics (United States)), Heba Abdelazeem(Inserm), Sonia Yung(Université Sorbonne Paris Nord), Dan Longrois(Hôpital Bichat-Claude-Bernard), Lucie H. Clapp(The London College), Yves Castier(Université Claude Bernard Lyon 1), Youcef Mahieddine(Inserm), Yasmine Amgoud(Inserm), Fangfang Li(Institute of Plant Protection), Amel Bouhadoun(Inserm), Jigisha Patel(University College London), Chabha Benyahia(Inserm)
Cited by 7
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Comfort and patient-centred care without excessive sedation: the eCASH concept
|Intensive Care Medicine|2016|429
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Terlipressin for norepinephrine-resistant septic shock
|The Lancet|2002|259
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study
|The Lancet Respiratory Medicine|2021|254